Selective serotonin reuptake inhibitors. Commercial interests should not influence prescribing
Tracey, D.
Bmj 309(6961): 1083-4; Author Reply 1085
1994
ISSN/ISBN: 0959-8138 PMID: 7950753 Document Number: 422695
Document emailed within 1 workday
Related Documents
Posternak, M.A.; Zimmerman, M. 2005: Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study Journal of Clinical Psychiatry 66(6): 705-707DeVane, C.L. 1992: Pharmacokinetics of the selective serotonin reuptake inhibitors Journal of Clinical Psychiatry 53 Suppl: 13-20
Mahendran, R. 2006: The risk of suicidality with selective serotonin reuptake inhibitors Annals of the Academy of Medicine Singapore 35(2): 96-99
Mayer, L.E.; Walsh, B.T. 1998: The use of selective serotonin reuptake inhibitors in eating disorders Journal of Clinical Psychiatry 59(Suppl): 28-34
Dudek, D.; Zieba, A.; Siwek, M.; Wróbel, A. 2004: Selective serotonin reuptake inhibitors--current knowledge Psychiatria Polska 38(3): 507-524
Condat, A.; Mouren-Simeoni, M.C. 2000: Selective serotonin reuptake inhibitors and depression in the child and adolescent L'Encephale 26(3): 53-60
Nakielny, J.; Eckett, S. 1994: Selective serotonin reuptake inhibitors. Calculation of costs is incorrect Bmj 309(6961): 1082-3; Author Reply 1085
Nelson, S.A.; Wilson, G.A.; Tucci, M.; Benghuzzi, H. 2015: The Effect of Selective Serotonin Reuptake Inhibitors and Antidiabetic Drugs on Cardiomyocytes Biomedical Sciences Instrumentation 51: 400-406
Ostroff, R.B.; Nelson, J.C. 1999: Risperidone augmentation of selective serotonin reuptake inhibitors in major depression Journal of Clinical Psychiatry 60(4): 256-259
Fonzo-Christe, C.; Vogt, N. 2000: Susceptibility of the elderly patient to hyponatremia induced by selective serotonin reuptake inhibitors Therapie 55(5): 597-604
Van Ermen, A.M.; Ottervanger, J.P.; Roisin, T.; Kurz, X.; Stricker, B.H. 1996: Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands Nederlands Tijdschrift Voor Geneeskunde 140(36): 1817-1820
Korendovych, I.V.; Svintsits'kyĭ, A.S.; Revenok, K.M.; Maliarov, S.O. 2014: Psychopharmacological approach with the usage of selective serotonin reuptake inhibitors in functional dyspepsia treatment Likars'ka Sprava 11: 58-64
Wan, G.J.; Crown, W.H.; Berndt, E.R.; Finkelstein, S.N.; Ling, D. 2002: Healthcare expenditure in patients treated with venlafaxine or selective serotonin reuptake inhibitors for depression and anxiety International Journal of Clinical Practice 56(6): 434-439
Kulin, N.A.; Pastuszak, A.; Sage, S.R.; Schick-Boschetto, B.; Spivey, G.; Feldkamp, M.; Ormond, K.; Matsui, D.; Stein-Schechman, A.K.; Cook, L.; Brochu, J.; Rieder, M.; Koren, G. 1998: Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study JAMA 279(8): 609-610
Nurnberg, H.G.; Thompson, P.M.; Hensley, P.L. 1999: Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors Journal of Clinical Psychiatry 60(9): 574-579
Yamauchi, M.; Hiraoka, S.; Imanishi, T. 2006: Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors Nihon Shinkei Seishin Yakurigaku Zasshi 26(5-6): 193-198
Pedrós, C.; Cereza, G.; Garcia, Núria. 2004: Hyponatremia and syndrome of inappropriate secretion of antidiuretic hormone induced by selective serotonin reuptake inhibitors: review of spontaneous reports Medicina Clinica 123(13): 516-517
Marangell, L.B.; Johnson, C.R.; Kertz, B.; Zboyan, H.A.; Martinez, J.M. 2002: Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study Journal of Clinical Psychiatry 63(5): 391-395
Appelberg, B.G.; Syvälahti, E.K.; Koskinen, T.E.; Mehtonen, O.P.; Muhonen, T.T.; Naukkarinen, H.H. 2001: Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study Journal of Clinical Psychiatry 62(6): 448-452
Bishop, J.R.; Ellingrod, V.L.; Akroush, M.; Moline, J. 2009: The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives Human Psychopharmacology 24(3): 207-215